Pharmaceutical Anti-counterfeiting Technologies; Play a Key Role in the Identification of Fake Medicines

Pharmaceutical Anti-counterfeiting Technologies

Pharmaceutical Anti-counterfeiting Technologies play an important role in the pharmaceutical industry as they help reduce counterfeiting of pharmaceutical products. Several techniques are being used by pharma companies to detect counterfeit, as pharmaceutical products are one of the most vulnerable goods to counterfeiting practices. Counterfeiting in the Pharmaceutical is a serious, pervasive threat; according to the World Health Organization (WHO), fake drugs drain the global economy of as much as US$ 200 billion in lost profits annually.

Moreover, around one in ten medical products circulating in low- and middle-income countries are either substandard or falsified, according to the WHO. Up to two billion people worldwide lack access to necessary medicines, vaccines, medical devices, which creates a vacuum that is too often filled by substandard and falsified products. Not only is this a waste of money for the health system and individuals who buy these products, but substandard or counterfeit medical products can cause serious illness or death.

There has been a sharp rise in Pharmaceutical Anti-counterfeiting Technologies Market during the pandemic. Moreover, the circulation of counterfeit drugs/devices/products has increased due to the acute shortage of medicines to treat COVID-19 (coronavirus) in the recent times. Therefore, there is an increasing demand for pharmaceutical anti-counterfeiting technologies across the globe, and to combat counterfeiting, pharmaceutical manufacturers and suppliers are working on adopting a worldwide standardized identification system.

The United States and European Union has a strong legal framework for counterfeit medicines. The Food and Drug Administration (FDA) remains vigilant in protecting the U.S. drug supply from counterfeits and other substandard drugs. Thus, there is an increasing demand for Pharmaceutical Anti-counterfeiting Technologies. Counterfeit pharmaceutical products can affect people in a variety of ways. The use of substandard medicines may result in treatment failure, adverse side effects, toxicity, resistance, and even death.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more